Software Test Engineer 2 at Illumina

Singapore, Singapore, Singapore

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Genomics, BiotechnologyIndustries

Requirements

Bachelor’s or master’s degree in computer science, Software Engineering, data science or a related field
Minimum 2 years of SQA experience in cloud software testing
Domain Knowledge in molecular biology and hands on experience in bioinformatics tools (plus)
Familiarity with CI/CD, Continuous Testing, and related tools such as Git, Jenkins
Familiarity with automation testing tools such as Selenium, JUnit, TestNG, or others
Experience writing verification plans, test cases, defects reports, executing & managing test cases using test cases management system and writing verification reports
Excellent problem-solving skills and the ability to think critically to identify potential issues and provide solutions

Responsibilities

Work with software engineers and bioinformatics scientists to understand analysis algorithms and architect & develop automated test solution(s)
Create detailed test cases that cover various scenarios to validate software functionality, performance, and security
Automate test cases for RESTful APIs and conduct end-to-end testing of web application
Identify, report, and track defects, working closely with the development team to ensure timely resolution
Prepare necessary test artifacts required for formal software / product release
Collaborate with developers, product managers, and other stakeholders to understand requirements and provide feedback on software quality
Contribute to the overall quality assurance process by participating in reviews, inspections, and audits

Skills

Test Automation

RESTful APIs

End-to-End Testing

Bioinformatics

Next-Generation Sequencing

Defect Tracking

Quality Assurance

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free